Summitry LLC Has $80.02 Million Stake in Agilent Technologies, Inc. $A

Summitry LLC raised its holdings in Agilent Technologies, Inc. (NYSE:A) by 2.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 623,468 shares of the medical research company’s stock after buying an additional 15,629 shares during the period. Agilent Technologies comprises about 3.4% of Summitry LLC’s holdings, making the stock its 8th largest position. Summitry LLC’s holdings in Agilent Technologies were worth $80,022,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Resona Asset Management Co. Ltd. grew its position in Agilent Technologies by 6.2% during the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after acquiring an additional 5,767 shares during the last quarter. CCLA Investment Management lifted its position in Agilent Technologies by 10.5% during the third quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock valued at $131,909,000 after buying an additional 97,312 shares during the period. TrueMark Investments LLC bought a new stake in shares of Agilent Technologies during the 2nd quarter valued at $1,999,000. Nuance Investments LLC increased its stake in shares of Agilent Technologies by 13.5% in the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after acquiring an additional 9,628 shares in the last quarter. Finally, Osaic Holdings Inc. grew its stake in shares of Agilent Technologies by 35.5% in the second quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock worth $8,017,000 after acquiring an additional 17,817 shares during the last quarter.

Agilent Technologies Price Performance

A stock opened at $125.80 on Monday. The stock has a market cap of $35.58 billion, a PE ratio of 27.53, a P/E/G ratio of 3.65 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The company has a 50-day moving average price of $137.84 and a 200 day moving average price of $135.53. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The company had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is currently 22.32%.

Insider Buying and Selling

In related news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of the firm’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the transaction, the chief executive officer owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure.

Analyst Upgrades and Downgrades

A number of research firms have commented on A. Barclays upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 target price on the stock in a research note on Monday, December 15th. Robert W. Baird raised their price target on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. HSBC began coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective for the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Finally, Morgan Stanley started coverage on shares of Agilent Technologies in a report on Tuesday, December 2nd. They issued an “overweight” rating for the company. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.